The elements of stem cell self-renewal: A genetic perspective

BioTechniques

Volumn 35, Issue 6, 2003, Pages 1240-1247

  Pazianos, Gregory ^a   Uqoezwa, Mweia ^a   Reya, Tannishtha ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD; CELLS; GENETIC ENGINEERING; TRANSPLANTATION (SURGICAL);

BONE MARROW;

BIOTECHNOLOGY;

NOTCH RECEPTOR; SONIC HEDGEHOG PROTEIN; WNT PROTEIN;

ANIMAL CELL; BONE MARROW TRANSPLANTATION; CELL FUNCTION; CELL PROLIFERATION; CELL RENEWAL; CELL SURVIVAL; CELL TYPE; CHROMOSOME SIZE; DNA MODIFICATION; HEMATOPOIETIC STEM CELL; HUMAN; HUMAN CELL; KNOCKOUT MOUSE; MEDIATOR; MICROENVIRONMENT; NONHUMAN; PHENOTYPE; REGULATORY MECHANISM; REVIEW; SELF RENEWAL; SENESCENCE; SIGNAL TRANSDUCTION; SOMATIC CELL GENETICS; STEM CELL; TELOMERE; TRANSGENIC MOUSE;

ANIMALIA; ERINACEIDAE; MUS MUSCULUS;

EID: 0345168036     PISSN: 07366205     EISSN: None     Source Type: Journal    
DOI: 10.2144/03356ss03     Document Type: Review

References (57)

1. Till, J. and E. McCulloch. 1961. A direct measurement of the radiation sensitivity of normal mouse bone marrow cells. Radiat. Res. 14:213-222.
2. Spangrude, G.J. and G.R. Johnson. 1990. Resting and activated subsets of mouse multipotent hematopoietic stem cells. Proc. Natl. Acad. Sci. USA 87:7433-7437.
3. Goodell, M.A., K. Brose, G. Paradis, A.S. Conner, and R.C. Mulligan. 1996. Isolation and functional properties of murine hematopoietic stem cells that are replicating in vivo. J. Exp. Med. 183:1797-1806.
4. Visser, J.W.M., J.G.J. Gauman, A.H. Mulder, J.E Eliason, and A.W. de Leeuw. 1984. Isolation of murine pluripotent hemopoietic stem cells. J. Exp. Med. 59:1576-1590.
5. Osawa, M., K. Hanada, H. Hamada, and H. Nakauchi. 1996. Long-term lymphohematopoietic reconstitution by a single CD34-low/negative hematopoietic stem cell. Science 273:242-245.
6. Adolfsson, J., O.J. Borge, D. Bryder, K. Theilgaard-Monch, I. Astrand-Grundstrom, E. Sitnicka, Y. Sasaki, and S.E. Jacobsen. 2001. Upregulation of Flt3 expression within the bone marrow Lin(-)Scal (+)c-kit(+) stem cell compartment is accompanied by loss of self-renewal capacity. Immunity 15:659-669.
7. Christensen, J.L. and I.L. Weissman. 2001. Flk-2 is a marker in hematopoietic stem cell differentiation: a simple method to isolate long-term stem cells. Proc. Natl. Acad. Sci. USA 98:14541-14546.
8. Spangrude, G.J., S. Heimfeld, and I.L. Weissman. 1988. Purification and characterization of mouse hematopoietic stem cells [published erratum appears in Science 1989 Jun 2;244(4908):1030]. Science 241:58-62.
9. Spangrude, G.J., S. Heimfeld, and I.L. Weissman. 1988. Purification and characterization of mouse hematopoietic stem cells [published erratum appears in Science 1989 Jun 2;244(4908):1030]. Science 241:58-62
10. Uchida, N. and I.L. Weissman. 1992. Searching for hematopoietic stem cells: evidence that Thy-1.110 Lin- Sca-1+ cells are the only stem cells in C57BL/Ka-Thy-1.1 bone marrow. J. Exp. Med. 175:175-184.
11. Morrison, S.J. and I.L. Weissman. 1994. The long-term repopulating subset of hematopoietic stem cells is deterministic and isolatable by phenotype. Immunity 1:661-673.
12. Domen, J., S.H. Cheshier, and I.L. Weissman. 2000. The role of apoptosis in the regulation of hematopoietic stem cells: overexpression of Bcl-2 increases both their number and repopulation potential. J. Exp. Med. 191:253-264.
13. Domen, J., K.L. Gandy, and I.L. Weissman. 1998. Systemic overexpression of BCL-2 in the hematopoietic system protects transgenic mice from the consequences of lethal irradiation. Blood 91:2272-2282.
14. Huang, D.C., L.A. O'Reilly, A. Strasser, and S. Cory. 1997. The anti-apoptosis function of Bcl-2 can be genetically separated from its inhibitory effect on cell cycle entry. EMBO J. 16:4628-4638.
15. O'Reilly, L.A., D.C. Huang, and A. Strasser. 1996. The cell death inhibitor Bcl-2 and its homologues influence control of cell cycle entry. EMBO J. 15:6979-6990.
16. Park, I.K., D. Qian, M. Kiel, M.W. Becker, M. Pihalja, I.L. Weissman, S.J. Morrison, and M.F. Clarke. 2003. Bmi-1 is required for maintenance of adult self-renewing haematopoietic stem cells. Nature 423:302-305.
17. Lessard, J. and G. Sauvageau. 2003. Bmi-1 determines the proliferative capacity of normal and leukaemic stem cells. Nature 423:255-260.
18. Jacobs, J.J., K. Kieboom, S. Marino, R.A. DePinho, and M. van Lohuizen. 1999. The oncogene and Polycomb-group gene bmi-1 regulates cell proliferation and senescence through the ink4a locus. Nature 397: 164-168.
19. Reya, T., S.J. Morrison, M.F. Clarke, and I.L. Weissman. 2001. Stem cells, cancer, and cancer stem cells. Nature 414:105-111.
20. Molofsky, A.V., R. Pardal, T. Iwashita, I.K. Park, M.F. Clarke, and S.J. Morrison. 2003. Bmi-1 dependence distinguishes neural stem cell self-renewal from progenitor proliferation. Nature 425:962-967.
21. Antonchuk, J., G. Sauvageau, and R.K. Humphries. 2002. HOXB4-induced expansion of adult hematopoietic stem cells ex vivo. Cell 109: 39-45.
22. Bjornsson, J.M., N. Larsson, A.C. Brun, M. Magnusson, E. Andersson, P. Lundstrom, J. Larsson, E. Repetowska, et al. 2003. Reduced proliferative capacity of hematopoietic stem cells deficient in Hoxb3 and Hoxb4. Mol. Cell. Biol. 23:3872-3883.
23. Magli, M.C., C. Largman, and H.J. Lawrence. 1997. Effects of HOX homeobox genes in blood cell differentiation. J. Cell Physiol. 173:168-177.
24. a. DiMartino, J.F., L. Selleri, D. Traver, M.T. Firpo, J. Rhee, R. Warnke, S. O'Gorman, I.L. Weissman, and M.L. Cleary. 2001. The Hox co-factor and proto-oncogene Pbx1 is required for maintenance of definitive hematopoiesis in the fetal liver. Blood 98:618-626.
25. Yu, B.D., J.L. Hess, S.E. Horning, G.A. Brown, and S.J. Korsmeyer. 1995. Altered Hox expression and segmental identity in M11-mutant mice. Nature 378:505-508.
26. Yagi, H., K. Deguchi, A. Aono, Y. Tani, T. Kishimoto, and T. Komori. 1998. Growth disturbance in fetal liver hematopoiesis of M11-mutant mice. Blood 92:108-117.
27. Cheshier, S.H., S.J. Morrison, X. Liao, and I.L. Weissman. 1999. In vivo proliferation and cell cycle kinetics of long-term hematopoietic stem cells. Proc. Natl. Acad. Sci. USA 96:3120-3125.
28. Cheng, T., N. Rodrigues, H. Shen, Y. Yang, D. Dombkowski, M. Sykes, and D.T. Scadden. 2000. Hematopoietic stem cell quiescence maintained by p21cip1/waf1. Science 287:1804-1808.
29. Cheng, T., N. Rodrigues, D. Dombkowski, S. Stier, and D.T. Scadden. 2000. Stem cell repopulation efficiency but not pool size is governed by p27(kip1). Nat. Med. 6:1235-1240.
30. Ohta, H., A. Sawada, J.Y. Kim, S. Tokimasa, S. Nishiguchi, R.K. Humphries, J. Hara, and Y. Takihara. 2002. Polycomb group gene rae28 is required for sustaining activity of hematopoietic stem cells. J. Exp. Med. 195:759-770.
31. Rebel, V.I., A.L. Kung, E.A. Tanner, H. Yang, R.T. Bronson, and D.M. Livingston. 2002. Distinct roles for CREB-binding protein and p300 in hematopoietic stem cell self-renewal. Proc. Natl. Acad. Sci. USA 99: 14789-14794.
32. Kung, A.L., V.I. Rebel, R.T. Bronson, L.E. Ch'ng, C.A. Sieff, D.M. Livingston, and T.P. Yao. 2000. Gene dose-dependent control of hematopoiesis and hematologic tumor suppression by CBP. Genes Dev. 14: 272-277.
33. Ito, C.Y., C.Y. Li, A. Bernstein, J.E. Dick, and W.L. Stanford. 2003. Hematopoietic stem cell and progenitor defects in Sca-1/Ly-6A-null mice. Blood 101:517-523.
34. Morrison, S.J., K.R. Prowse, P. Ho, and I.L. Weissman. 1996. Telomerase activity in hematopoietic cells is associated with self-renewal potential. Immunity 5:207-216.
35. Allsopp, R.C., S. Cheshier, and I.L. Weissman. 2001. Telomere shortening accompanies increased cell cycle activity during serial transplantation of hematopoietic stem cells. J. Exp. Med. 193:917-924.
36. Allsopp, R.C., G.B. Morin, R. DePinho, C.B. Harley, and I.L. Weissman. 2003. Telomerase is required to slow telomere shortening and extend replicative lifespan of HSCs during serial transplantation. Blood 102:517-520.
37. Allsopp, R.C., G.B. Morin, J.W. Horner, R. DePinho, C.B. Harley, and I.L. Weissman. 2003. Effect of TERT over-expression on the long-term transplantation capacity of hematopoietic stem cells. Nat. Med. 9: 369-371.
38. Varnum-Finney, B., L. Xu, C. Brashem-Stein, C. Nourigat, D. Flowers, S. Bakkour, W.S. Pear, and I.D. Bernstein. 2000. Pluripotent, cytokine-dependent, hematopoietic stem cells are immortalized by constitutive Notch1 signaling. Nat. Med. 6:1278-1281.
39. Stier, S., T. Cheng, D. Dombkowski, N. Carlesso, and D.T. Scadden. 2002. Notch1 activation increases hematopoietic stem cell self-renewal in vivo and favors lymphoid over myeloid lineage outcome. Blood 99: 2369-2378.
40. Karanu, F.N., B. Murdoch, L. Gallacher, D.M. Wu, Koremoto, S. Sakano, and M. Bhatia. 2000. The notch ligand jagged-1 represents a novel growth factor of human hematopoietic stem cells. J. Exp. Med. 192: 1365-1372.
41. Artavanis-Tsakonas, S., K. Matsuno, and M.E. Fortini. 1995. Notch Signaling. Science 268:225-232.
42. Kumano, K., S. Chiba, A. Kunisato, M. Sata, T. Saito, E. Nakagami-Yamaguchi, T. Yamaguchi, S. Masuda, et al. 2003. Notch1 but not Notch2 is essential for generating hematopoietic stem cells from endothelial cells. Immunity 18:699-711.
43. Radtke, F., A. Wilson, G. Stark, M. Bauer, J. van Meerwijk, H.R. MacDonald, and M. Aguet. 1999. Deficient T cell fate specification in mice with an induced inactivation of Notch1. Immunity 10:547-558.
44. Calvi, L.M., G.B. Adams, K.W. Weibrecht, J.M. Weber, D.P. Olson, M.C. Knight, R.P. Martin, E. Schipani, et al. 2003. Osteoblastic cells regulate the haematopoietic stem cell niche. Nature 425:841-846.
45. Porcher, C., W. Swat, K. Rockwell, Y. Fujiwara, F.W. Alt, and S.H. Orkin. 1996. The T cell leukemia oncoprotein SCL/tal-1 is essential for development of all hematopoietic lineages. Cell 86:47-57.
46. Mikkola, H.K., J. Klintman, H. Yang, H. Hock, T.M. Schlaeger, Y. Fujiwara, and S.H. Orkin. 2003. Haematopoietic stem cells retain long-term repopulating activity and multipotency in the absence of stem-cell leukaemia SCL/tal-1 gene. Nature 421:547-551.
47. Bhardwaj, G., B. Murdoch, D. Wu, D.P. Baker, K.P. Williams, K. Chadwick, L.E. Ling, F.N. Karanu, and M. Bhatia. 2001. Sonic hedgehog induces the proliferation of primitive human hematopoietic cells via BMP regulation. Nat. Immunol. 2:172-180.
48. Rowitch, D.H., S.-Jacques B., S.M. Lee, J.D. Flax, E.Y. Snyder, and A.P. McMahon. 1999. Sonic hedgehog regulates proliferation and inhibits differentiation of CNS precursor cells. J. Neurosci. 19:8954-8965.
49. Wechsler-Reya, R.J. and M.P. Scott. 1999. Control of neuronal precursor proliferation in the cerebellum by Sonic Hedgehog. Neuron 22: 103-114.
50. Wechsler-Reya, R. and M.P. Scott. 2001. The developmental biology of brain tumors. Annu. Rev. Neurosci. 24:385-428.
51. Gailani, M.R. and A.E. Bale. 1999. Acquired and inherited basal cell carcinomas and the patched gene. Adv. Dermatol. 14:261-283.
52. Reya, T. 2003. Regulation of hematopoietic stem cell self-renewal. Recent Prog. Horm. Res. 58:283-295.
53. Austin, T.W., G.P. Solar, F.C. Ziegler, L. Liem, and W. Matthews. 1997. A role for the Wnt gene family in hematopoiesis: expansion of multilineage progenitor cells. Blood 89:3624-3635.
54. Van Den Berg, D.J., A.K. Sharma, E. Bruno, and R. Hoffman. 1998. Role of members of the Wnt gene family in human hematopoiesis. Blood 92:3189-3202.
55. Reya, T., A.W. Duncan, L. Ailles, J. Domen, D.C. Scherer, K. Willert, L. Hintz, R. Nusse, and I.L. Weissman. 2003. A role for Wnt signalling in self-renewal of haematopoietic stem cells. Nature 423:409-414.
56. Willert, K., J.D. Brown, E. Danenberg, A.W. Duncan, I.L. Weissman, T. Reya, J.R. Yates III, and R. Nusse. 2003. Wnt proteins are lipid-modified and can act as stem cell growth factors. Nature 423:448-452.
57. Murdoch, B., K. Chadwick, M. Martin, F. Shojaei, K.V. Shah, L. Gallacher, R.T. Moon, and M. Bhatia. 2003. Wnt-5A augments repopulating capacity and primitive hematopoietic development of human blood stem cells in vivo. Proc. Natl. Acad. Sci. USA 100:3422-3427.